Key Finding
Only five studies met quality criteria, showing acupuncture reduced pain intensity and improved school attendance and social functioning in pediatric patients, though evidence remains weak due to small sample sizes and design limitations.
Researchers conducted a systematic review to examine whether acupuncture can help children and young adults manage chronic pain. They searched medical databases for clinical studies involving participants up to 22 years old who received acupuncture treatment for ongoing pain conditions.
The research team found only five studies that met their quality standards out of nearly 2,400 articles initially identified. These five studies included two case series, two single-arm studies, and one randomized clinical trial. While the number of studies was small, all were considered good quality by the assessment criteria used.
The results showed promising benefits for young patients. Children and adolescents who received acupuncture experienced reduced pain intensity, which is the primary goal of any pain treatment. Beyond just pain relief, patients also showed improvements in their daily lives—they attended school more regularly and were better able to participate in social activities. These quality-of-life improvements are especially important for young people whose pain might otherwise interfere with normal development and social connections.
However, the researchers noted significant limitations. The studies had small numbers of participants and varied in how they were designed, making it difficult to draw strong conclusions. The scientific evidence supporting acupuncture for pediatric chronic pain is currently weak, though the positive results are encouraging.
What this means for families: Acupuncture may be worth considering as part of a comprehensive pain management plan for children with chronic pain, but more research is needed to fully understand its effectiveness. If you're considering acupuncture for your child, seek a qualified, licensed practitioner with specific experience treating pediatric patients.
This systematic review following PRISMA guidelines searched MEDLINE, Scopus, and Scielo databases for clinical studies of acupuncture in pediatric chronic pain (ages ≤22 years). Of 2,369 articles retrieved, only 5 met inclusion criteria: two case series, two single-arm studies, and one RCT. Study quality was assessed using MMAT, with the RCT evaluated under STRICTA criteria; all studies were rated as good quality.
Clinical outcomes demonstrated pain intensity reduction and improvements in school attendance and social functioning. However, significant methodological limitations included small sample sizes and heterogeneous study designs. No specific effect sizes were reported in the abstract.
Clinical implications: While existing evidence is weak due to limited high-quality studies, the consistent positive findings across available research suggest acupuncture may have therapeutic value for pediatric chronic pain management. The improvements in functional outcomes (school attendance, social participation) are particularly relevant for this population. Well-designed, adequately powered RCTs are urgently needed to establish evidence-based protocols and determine clinical efficacy in pediatric settings before widespread clinical implementation can be recommended.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 Among patients with moderate-to-severe chronic pain, depression, anxiety, and sleep disturbance affect 36.6%, 19.1%, and 46.3% respectively, with pain interference and alcohol consumption emerging as modifiable factors associated with multiple psychological comorbidities.
📌 An integrated treatment approach combining acupotomy at trigger points, specific acupuncture point combinations targeting wind dispersion, herbal medicine, and bloodletting may provide holistic management of primary trigeminal neuralgia according to one expert's clinical experience.
📌 The ATP-P2X7-NLRP3 signaling axis represents a shared molecular mechanism driving cell death and chronic inflammation in both degenerative bone diseases and cardiovascular diseases, suggesting common therapeutic targets across these conditions.